arrow
M

Mengna Huang

brown university
H指数:20
被引数:2,236

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies

IBI351 (fulzerasib) 单药治疗未使用KRASG12C抑制剂的中国KRASG12C-mutated转移性结直肠癌患者的疗效和安全性: 两项研究的I期汇总分析

2025-07-250
OAAI
Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study

晚期实体瘤患者中KRAS G12C IBI351的有效共价不可逆抑制剂: 首次人体I期研究

2024-11-010
PRE
Metabolite signatures associated with microRNA miR-143-3p serve as drivers of poor lung function trajectories in childhood asthma
2024-04-011
OAAI
Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors

鞘脂课程及其与儿童哮喘和哮喘危险因素的相互关系

2023-11-282
PRE
Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma (vol 28, pg 814, 2022)

代谢组学分析揭示了哮喘吸入糖皮质激素治疗引起的广泛肾上腺抑制 (第28卷,814页,2022页)

2022-07-202
OA
Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation

2型糖尿病的多血统遗传研究突出了不同人群发现和翻译的力量

2022-05-12275
OAAI
Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma

代谢组学分析显示哮喘吸入糖皮质激素治疗引起的广泛肾上腺抑制

2022-03-2153
OA
Defining the Scope of Exposome Studies and Research Needs from a Multidisciplinary Perspective
2021-09-0774
OAAI